High efficacy of the combination chemotherapy (CT) of oral vinorelbine (NVBO) and capecitabine (X) with trastuzumab (H) in HER2-positive metastatic breast cancer (MBC): updated analysis of the results of an international phase 2 trial

Abstract

Chemotherapy; vinorelbine; capecitabine; trastuzumab; metastatic breast cancer